Company: BIAF
Filing Date: 2025-09-25
Form Type: S-1/A
Source: 0001493152-25-014878
Chunk: 43

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-25
Form: S-1/A
Chunk 43
---
 laws such as the Foreign Corrupt Practices Act; and                                        |
| ● | covenants                                                                                                                            
 regarding matters such as registration of shares issued and issuable upon exercise of the Pre-Funded Warrants, no integration        
 with other offerings, no shareholder rights plans, use of proceeds, indemnification of purchasers, reservation and listing of Common 
 Stock, and no subsequent equity sales for 30 days.                                                                                   |

Delivery of the shares of Common Stock and Pre-Funded Warrants offered hereby is expected to occur on or about , 2025, subject to satisfaction of certain customary closing conditions.

Fees and Expenses

The following table shows the per share price and total cash fees we will pay to the Placement Agent in connection with the sale of the securities pursuant to this prospectus.

|                                |     | Per   
 Share |     | Per Pre-Funded Warrant |     | Total |
|:-------------------------------|:----|:------|:----|:-----------------------|:----|:------|
| Public offering price          |     | $     |     | $                      |     | $     |
| Placement Agent fees           |     | $     |     | $                      |     | $     |
| Proceeds before expenses to us |     | $     |     | $                      |     | $     |

We have
agreed to pay the Placement Agent a total cash fee equal to 8.0% of the gross proceeds of this offering. We will also reimburse the Placement
Agent’s legal fees and expenses in an amount up to $120,000.

| 27 |

We estimate the total expenses of this offering paid or payable by us, exclusive of the Placement Agent’s cash fee and expenses payable by us, will be approximately $280,000. After deducting the fees and expenses due to the Placement Agent and our estimated expenses in connection with this offering, assuming we sell all of the shares and accompanying warrants offered hereby, we expect the net proceeds from this offering will be approximately $3.4 million (assuming $4 million on gross proceeds are received).

Placement Agent Warrants

In addition, we have agreed to issue to the Placement Agent or its designees Placement Agent Warrants to purchase up to 3.0% of the aggregate number of shares of Common Stock sold in this offering (including shares underlying any Pre-Funded Warrants), at an exercise price equal to 110% of the public offering price per share to be sold in this offering. The Placement Agent Warrants will be